Richard E Philion

Title: Innovations of Richard E Philion

Introduction

Richard E Philion is a notable inventor based in Pottstown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 4 patents to his name, Philion's work has the potential to impact medical treatments and drug formulations.

Latest Patents

One of his latest patents involves CB.sub.2 receptor agonist compounds. This patent discloses the use of human CB.sub.2 receptor-specific agonists for preparing immunomodulating drugs. The detailed formula includes various groups and substitutions that enhance the efficacy of these compounds. Another notable patent is the process for preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis-hydrazine carboximidamide, showcasing his expertise in chemical synthesis.

Career Highlights

Philion is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to work on cutting-edge research and development projects that aim to bring innovative solutions to the pharmaceutical industry. His contributions have been instrumental in advancing the company's portfolio of therapeutic options.

Collaborations

Throughout his career, Philion has collaborated with talented professionals, including Murielle Rinaldi and Francis Barth. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Richard E Philion's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes. His contributions are a testament to the importance of research and development in creating effective therapeutic solutions.